References
Stone JH, Merkel PA, Spiera R et al (2010) Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis. N Engl J Med 363(3):221–232. doi:10.1056/NEJMoa0909905
Suppiah R, Hadden RD, Batra R et al (2011) Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials. Rheumatology (Oxford) 50(12):2214–2222. doi:10.1093/rheumatology/ker266
Dyck PJ, Lais AC, Ohta M et al (1975) Chronic inflammatory polyradiculoneuropathy. Mayo Clin Proc 50:621
Kyle RA, Greipp PR (1983) Amyloidosis (AL). Clinical and laboratory features in 229 cases. Mayo Clin Proc 58(10):665–683
Dispenzieri A, Kyle RA, Lacy MQ et al (2003) POEMS syndrome: definitions and long-term outcome. Blood 101(7):2496–2506
Tymms KE, Webb J (1985) Dermatopolymyositis and other connective tissue diseases: a review of 105 cases. J Rheumatol 12(6):1140–1148
Romero NB, Clarke NF (2013) Congenital myopathies. Handb Clin Neurol 113:1321–1336. doi:10.1016/B978-0-444-59565-2.00004-6
Minetto MA, Lanfranco F, Motta G et al (2011) Steroid myopathy: some unresolved issues. J Endocrinol Invest 34(5):370–375
Stroes ES, Thompson PD, Corsini A et al (2015) Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management. Eur Heart J 36(17):1012–1022. doi:10.1093/eurheartj/ehv043
Bruckert E, Hayem G, Dejager S et al (2005) Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients—the PRIMO study. Cardiovasc Drugs Ther 19:403–414
Ajmone-Marsan C, Goldhammer L (1973) Clinical ictal patterns and electrographic data in cases of partial seizures of fronto-central-parietal origin. Epilepsy, its Phenomenon in Man. Academic Press, San Diego, pp 235–258
Hogan SL, Falk RJ, Chin H et al (2005) Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Ann Intern Med 143(9):621–631
Russell KA, Fass DN, Specks U (2001) Antineutrophil cytoplasmic antibodies reacting with the pro form of proteinase 3 and disease activity in patients with Wegener’s granulomatosis and microscopic polyangiitis. Arthritis Rheum 44(2):463–468
Watts R, Lane S, Hanslik T et al (2007) Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 66(2):222–227 (PubMed PMID: 16901958; PubMed Central PMCID: PMC1798520)
Fokke C, van den Berg B, Drenthen J et al (2000) Diagnosis of Guillain–Barré syndrome and validation of Brighton criteria. Brain 137(Pt 1):33–43. doi:10.1093/brain/awt285
Lorell BH, Carabello BA (2000) Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation 102(4):470–479
Maron BJ, Mathenge R, Casey SA et al (1999) Clinical profile of hypertrophic cardiomyopathy identified de novo in rural communities. J Am Coll Cardiol 33(6):1590–1595
Richard P, Charron P, Carrier L et al (2003) Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 107(17):2227–2232 [Erratum in: Circulation 109(25):3258 (2004 Jun 29)]
Winchester B, Vellodi A, Young E (2000) The molecular basis of lysosomal storage diseases and their treatment. Biochem Soc Trans 28(2):150–154
Carubbi F, Bonilauri L (2012) Fabry disease: raising awareness of the disease among physicians. Intern Emerg Med 7(suppl 3):S227–S231. doi:10.1007/s11739-012-0821-x
Lidove O, Kaminsky P, Hachulla E et al (2012) Fabry disease ‘The New Great Imposter’: results of the French Observatoire in Internal Medicine Departments (FIMeD). Clin Genet 81(6):571–577. doi:10.1111/j.1399-0004.2011.01718
Eng CM, Fletcher J, Wilcox WR et al (2007) Fabry disease: baseline medical characteristics of a cohort of 1765 males and females in the Fabry Registry. J Inherit Metab Dis 30(2):184–192
Okuda S (2000) Renal involvement in Fabry’s disease. Intern Med 39(8):601–602
Hanaoka H, Hashiguchi A, Konishi K et al (2014) A rare association between Fabry’s disease and granulomatosis with polyangiitis: a potential pathogenic link. BMC Nephrol 15:157. doi:10.1186/1471-2369-15-157
Acknowledgements
The authors would like to thank the patient who kindly accepted the report of his case.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Statement of human and animal rights
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent
For this type of study formal consent is not required.
Rights and permissions
About this article
Cite this article
Fraticelli, P., Cardinali, M., Biondi, L. et al. A painful diagnosis. Intern Emerg Med 12, 341–347 (2017). https://doi.org/10.1007/s11739-017-1638-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-017-1638-4